If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "Synapse Biomedical"
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 16: | Line 16: | ||
[https://www.crunchbase.com/organization/synapse-biomedical Crunchbase] | [https://www.crunchbase.com/organization/synapse-biomedical Crunchbase] | ||
[https://www.linkedin.com/company/synapse-biomedical/ LinkedIn] | [https://www.linkedin.com/company/synapse-biomedical/ LinkedIn] | ||
| + | [https://twitter.com/synapsedps Twitter][https://facebook.com/synapsedps Facebook] | ||
Revision as of 23:57, 21 March 2022
Synapse Biomedical Inc (SBI) was founded in September 2002 to commercialize the NeuRx Diaphragm Pacing System (DPS)r that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency.
Founded in The United States around 2002, Synapse Biomedical produces invasive hardware.
Synapse Biomedical makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): PNS